ABCB1 and neoplasm: However, chemosensitivities towards MDR-related as well as non-related antitumour compounds measured by high throughput screening in tumour cell lines harbouring gain-of-function or wt β-catenin did not differ despite their differences in β-catenin genotype and ABCB1 expression levels.